Fennec Pharmaceuticals Inc. (FENC) Q4 2024 Earnings Call Transcript

2025-03-10 10:24:58 ET

Fennec Pharmaceuticals Inc. (FENC)

Q4 2024 Earnings Conference Call

March 10, 2025, 08:30 AM ET

Company Participants

Robert Andrade - CFO

Jeff Hackman - CEO and Board Member

Conference Call Participants

Chase Knickerbocker - Craig-Hallum

Raghuram Selvaraju - H.C. Wainwright

Felix Ampomah - Stephens

Michael Okunewitch - Maxim Group

Presentation

Operator

Good morning, ladies and gentlemen, and welcome to Fennec Pharmaceuticals Fourth Quarter and Full Year 2024 Earnings and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions on how to participate will begin at that time. As a reminder, today's conference call is being recorded.

Now I would like to turn the conference over to Fennec's Chief Financial Officer, Robert Andrade. Please go ahead.

Robert Andrade

Thank you, operator, and good morning, everyone. We appreciate you joining us today for Fennec Pharmaceuticals fourth quarter and full year 2024 earnings conference call, during which we will review our financial results as well as provide a general business update.

Joining me from Fennec this morning is our Chief Executive Officer and Board Member, Jeff Hackman....

Read the full article on Seeking Alpha

For further details see: